• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Pluristem Therapeutics Inc

+ Add to Watchlist

PSTI:US

2.9700 USD 0.1700 6.07%

As of 15:59:51 ET on 09/17/2014.

Company Profile for Pluristem Therapeutics Inc (PSTI)

Pluristem Therapeutics, Inc. develops Messenchymal stem cell production technology and commercializes cell therapy products. The Company focuses on cell therapy to treat severe blood, cardiovascular, autoimmune, and other disorders.

Contact Information

Pluristem Therapeutics Inc

Matam Advanced Technology Park
Building 20
Haifa, 31905
Israel
Phone: 972-74-710-7171

Key Executives for Pluristem Therapeutics Inc (PSTI)

Zami AbermanChief Executive OfficerYaky YanayPresident/COO
Boaz Gur-LavieCFO/Secretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil